- Home
- XEL vs TEVA Comparison
XEL vs TEVA Comparison
Compare XEL & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XEL | TEVA |
|---|---|---|
| Founded | 1909 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.9B | 40.5B |
| IPO Year | 2003 | 1996 |
Fundamental Metrics
Financial Performance| Metric | XEL | TEVA |
|---|---|---|
| Price | $72.01 | $39.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $89.00 | $38.63 |
| AVG Volume (30 Days) | ★ 5.0M | 4.0M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.89% | N/A |
| EPS Growth | N/A | ★ 183.45 |
| EPS | ★ 1.82 | N/A |
| Revenue | ★ $11,537,000,000.00 | N/A |
| Revenue This Year | $9.77 | N/A |
| Revenue Next Year | $8.32 | $2.97 |
| P/E Ratio | $39.48 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $71.67 | $18.21 |
| 52 Week High | $84.23 | $40.79 |
Technical Indicators
Market Signals| Indicator | XEL | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 30.12 | 64.06 |
| Support Level | N/A | $30.42 |
| Resistance Level | $83.15 | N/A |
| Average True Range (ATR) | 1.22 | 1.25 |
| MACD | -0.32 | 0.19 |
| Stochastic Oscillator | 1.02 | 78.40 |
Price Performance
Historical ComparisonAbout XEL Xcel Energy Inc.
Xcel Energy manages utilities serving 3.9 million electric customers and 2.2 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan; Public Service Company of Colorado; and Southwestern Public Service Company, which serves customers in Texas and New Mexico. It is one of the largest renewable energy suppliers in the US, with more than half of its electricity sales coming from carbon-free energy.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.